Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Rubin Lab
Explore this Website
Home
News
About Us
Research
Lab Team
Publications
Resources
Toggle Resources menu options
FISH
Profiler
Tracking Samples
Weill Cornell Medicine
Care
Discover
Teach
Home
News
About Us
Research
Lab Team
Publications
Resources
Home
Publications
Publications
Found 115 results
Author
Title
Type
Year
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
R
Rubin MA
. 2015.
Health: Make precision medicine work for cancer care.
.
Nature. 520(7547):290-1.
Rubin MA
. 2004.
Using molecular markers to predict outcome.
.
J Urol. 172(5 Pt 2):S18-21;discussionS21-2.
Rubin MA
. 2008.
Targeted therapy of cancer: new roles for pathologists--prostate cancer.
.
Mod Pathol. 21 Suppl 2:S44-55.
Rubin MA
. 2012.
ETS rearrangements in prostate cancer.
.
Asian J Androl. 14(3):393-9.
Rubin MA
,
Varambally S
,
Beroukhim R
,
Tomlins SA
,
Rhodes DR
,
Paris PL
,
Hofer MD
,
Storz-Schweizer M
,
Kuefer R
,
Fletcher JA
et al.
. 2004.
Overexpression, amplification, and androgen regulation of TPD52 in prostate cancer.
.
Cancer Res. 64(11):3814-22.
Robinson D
,
Van Allen EM
,
Wu Y-M
,
Schultz N
,
Lonigro RJ
,
Mosquera J-M
,
Montgomery B
,
Taplin M-E
,
Pritchard CC
,
Attard G
et al.
. 2015.
Integrative clinical genomics of advanced prostate cancer.
.
Cell. 161(5):1215-28.
Rickman DS
,
Pflueger D
,
Moss B
,
VanDoren VE
,
Chen CX
,
de la Taille A
,
Kuefer R
,
Tewari AK
,
Setlur SR
,
Demichelis F
et al.
. 2009.
SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer.
.
Cancer Res. 69(7):2734-8.
Rickman DS
,
T Soong D
,
Moss B
,
Mosquera JMiguel
,
Dlabal J
,
Terry S
,
MacDonald TY
,
Tripodi J
,
Bunting K
,
Najfeld V
et al.
. 2012.
Oncogene-mediated alterations in chromatin conformation.
.
Proc Natl Acad Sci U S A. 109(23):9083-8.
Rickman DS
,
Chen Y-B
,
Banerjee S
,
Pan Y
,
Yu J
,
Vuong T
,
Perner S
,
Lafargue CJ
,
Mertz KD
,
Setlur SR
et al.
. 2010.
ERG cooperates with androgen receptor in regulating trefoil factor 3 in prostate cancer disease progression.
.
Neoplasia. 12(12):1031-40.
P
Pritchard CC
,
Mateo J
,
Walsh MF
,
De Sarkar N
,
Abida W
,
Beltran H
,
Garofalo A
,
Gulati R
,
Carreira S
,
Eeles R
et al.
. 2016.
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer
.
N Engl J Med.
Prensner JR
,
Rubin MA
,
Wei JT
,
Chinnaiyan AM
. 2012.
Beyond PSA: the next generation of prostate cancer biomarkers.
.
Sci Transl Med. 4(127):127rv3.
Pflueger D
,
Rickman DS
,
Sboner A
,
Perner S
,
Lafargue CJ
,
Svensson MA
,
Moss BJ
,
Kitabayashi N
,
Pan Y
,
de la Taille A
et al.
. 2009.
N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancer.
.
Neoplasia. 11(8):804-11.
Pflueger D
,
Terry S
,
Sboner A
,
Habegger L
,
Esgueva R
,
Lin P-C
,
Svensson MA
,
Kitabayashi N
,
Moss BJ
,
MacDonald TY
et al.
. 2011.
Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing.
.
Genome Res. 21(1):56-67.
Perner S
,
Demichelis F
,
Beroukhim R
,
Schmidt FH
,
Mosquera J-M
,
Setlur S
,
Tchinda J
,
Tomlins SA
,
Hofer MD
,
Pienta KG
et al.
. 2006.
TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer.
.
Cancer Res. 66(17):8337-41.
Perner S
,
Hofer MD
,
Kim R
,
Shah RB
,
Li H
,
Möller P
,
Hautmann RE
,
Gschwend JE
,
Kuefer R
,
Rubin MA
. 2007.
Prostate-specific membrane antigen expression as a predictor of prostate cancer progression.
.
Hum Pathol. 38(5):696-701.
Perner S
,
Svensson MA
,
Hossain RR
,
Day JR
,
Groskopf J
,
Slaughter RC
,
Jarleborn AR
,
Hofer MD
,
Kuefer R
,
Demichelis F
et al.
. 2010.
ERG rearrangement metastasis patterns in locally advanced prostate cancer.
.
Urology. 75(4):762-7.
Perner S
,
Wagner PL
,
Soltermann A
,
LaFargue C
,
Tischler V
,
Weir BA
,
Weder W
,
Meyerson M
,
Giordano TJ
,
Moch H
et al.
. 2009.
TTF1 expression in non-small cell lung carcinoma: association with TTF1 gene amplification and improved survival.
.
J Pathol. 217(1):65-72.
Perner S
,
Mosquera J-M
,
Demichelis F
,
Hofer MD
,
Paris PL
,
Simko J
,
Collins C
,
Bismar TA
,
Chinnaiyan AM
,
De Marzo AM
et al.
. 2007.
TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion.
.
Am J Surg Pathol. 31(6):882-8.
Perner S
,
Wagner PL
,
Demichelis F
,
Mehra R
,
Lafargue CJ
,
Moss BJ
,
Arbogast S
,
Soltermann A
,
Weder W
,
Giordano TJ
et al.
. 2008.
EML4-ALK fusion lung cancer: a rare acquired event.
.
Neoplasia. 10(3):298-302.
Pauli C
,
Hopkins BD
,
Prandi D
,
Shaw R
,
Fedrizzi T
,
Sboner A
,
Sailer V
,
Augello M
,
Puca L
,
Rosati R
et al.
. 2017.
Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine.
.
Cancer Discov.
Pauli C
,
Puca L
,
Mosquera JMiguel
,
Robinson BD
,
Beltran H
,
Rubin MA
,
Rao RA
. 2016.
An emerging role for cytopathology in precision oncology.
.
Cancer Cytopathol. 124(3):167-73.
Park K
,
Dalton JT
,
Narayanan R
,
Barbieri CE
,
Hancock ML
,
Bostwick DG
,
Steiner MS
,
Rubin MA
. 2014.
TMPRSS2:ERG gene fusion predicts subsequent detection of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia.
.
J Clin Oncol. 32(3):206-11.
Park K
,
Tomlins SA
,
Mudaliar KM
,
Chiu Y-L
,
Esgueva R
,
Mehra R
,
Suleman K
,
Varambally S
,
Brenner JC
,
MacDonald T
et al.
. 2010.
Antibody-based detection of ERG rearrangement-positive prostate cancer.
.
Neoplasia. 12(7):590-8.
M
Mu P
,
Zhang Z
,
Benelli M
,
Karthaus WR
,
Hoover E
,
Chen C-C
,
Wongvipat J
,
Ku S-Y
,
Gao D
,
Cao Z
et al.
. 2017.
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer.
.
Science. 355(6320):84-88.
Mosquera J-M
,
Perner S
,
Demichelis F
,
Kim R
,
Hofer MD
,
Mertz KD
,
Paris PL
,
Simko J
,
Collins C
,
Bismar TA
et al.
. 2007.
Morphological features of TMPRSS2-ERG gene fusion prostate cancer.
.
J Pathol. 212(1):91-101.
« first
‹ previous
1
2
(current)
3
4
5
next ›
last »